Offer - Urjas Oil for just ₹ 1 X
Akudin T is a prescription drug, available for use as Drops. The alternative uses of Akudin T have also been explained below.
Medical history of the patient along with age and gender determines the dosage of Akudin T. The condition it has been prescribed for, and the route of administration also determine the right dosage. This information has been provided in detail in the dosage section.
Akudin T also has some side effects, the most common being Eye Burning, Eye irritation, Stinging in the Eyes. While these are the most often observed Akudin T side effects, there are can be others also. These have been listed below. Normally, these side effects of Akudin T are not long lasting and go away when the treatment is finished. Consult your doctor if these side effects become worse or stay for a longer duration.
Akudin T's effect during pregnancy is Mild and Unknown while nursing. It is important to know if Akudin T has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Akudin T related warnings section.
Akudin T can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Akudin T in conditions like Heart Failure, Diabetes, COPD (Chronic Obstructive Pulmonary Disease). Some other conditions that can be affected by Akudin T are listed in the contraindications section below.
Drug interactions for Akudin T have been reported in the medical literature. Refer to the list below for further details.
In addition to these precautions, you may also note that Akudin T is safe while driving, and is is addictive in nature.
Akudin T is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Adult |
|
Geriatric |
|
Is the use of Akudin T safe for pregnant women?
Pregnant women may get mild side effects from Akudin T.
Is the use of Akudin T safe during breastfeeding?
In the absence of any scientific study about the side effects of Akudin T in breastfeeding women, information on safety of Akudin T is unavailable.
What is the effect of Akudin T on the Kidneys?
Kidney can be affected by Akudin T. If you experience any unwanted effects of this drug, stop taking it. You should take it again only after medical advice.
What is the effect of Akudin T on the Liver?
There may be an adverse effect on the liver after taking Akudin T. If you observe any side effects on your body then stop taking this drug. Take this medicine again only if your doctor advises you to do so.
What is the effect of Akudin T on the Heart?
You may experience side effects on your heart after taking Akudin T. If this happens, then discontinue its use. Consult your medical practitioner, and do as he/she suggests.
Akudin T should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Akudin T unless your doctor advises you to do so -
Is this Akudin T habit forming or addictive?
No, you will not get addicted to Akudin T.
Interaction between Food and Akudin T
Taking Akudin T with food does not harm your health.
Interaction between Alcohol and Akudin T
Information about the interaction of Akudin T and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Istalol® (timolol maleate ophthalmic solution)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1401
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 153
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1405
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 154
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Alphagan® (brimonidine tartrate)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Simbrinza™ (brinzolamide/brimonidine tartrate)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Enidin® (brimonidine tartrate)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Alphagan® P (brimonidine tartrate)